SCHEMBL29630979

SCHEMBL29630979

O=C(O)c1cccc(N2CCCCC2)c1

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.96
HSD17B10 Q99714 4/20 0.96
KDM4E B2RXH2 4/20 0.96
GAA P10253 4/20 0.96
HPGD P15428 3/20 0.96
MEN1 O00255 2/20 0.96
KMT2A Q03164 2/20 0.96
KMO O15229 1/20 0.71
CYP2D6 P10635 2/20 0.59
CYP2C9 P11712 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C19 P33261 1/20 0.59
POLB P06746 3/20 0.59
GFER P55789 1/20 0.57
HIF1A Q16665 1/20 0.55
TTR P02766 1/20 0.55
MAPT P10636 5/20 0.54
L3MBTL1 Q9Y468 4/20 0.54
NPC1 O15118 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1517128 1.00 ALDH1A1 (0.96) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL3105857 1.00 ALDH1A1 (0.96) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL29717077 0.98 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL1517203 0.98 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL32688379 0.87 ALDH1A1 (0.80) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL16595440 0.86 ALDH1A1 (0.73) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL1397690 0.86 GAA (0.72) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL30290422 0.86 GAA (0.72) ALDH1A1HSD17B10KDM4EGAAHPGD
SCHEMBL8349198 0.84 ALDH1A1 (0.70) ALDH1A1HSD17B10KDM4EGAAHPGD
Hydrochloric Acid SCHEMBL4630423 0.84 GAA (0.70) ALDH1A1HSD17B10KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed
CN-117396462-A Antiviral compounds 英菲克斯治疗有限公司 2024-01-12 CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 US disclosed
CN-109563094-B (hetero) aryl-substituted piperidinyl derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2022-03-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885HSD17B10 30/4885KDM4E 3207/4885
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT ALDH1A1 982/4885HSD17B10 1583/4885KDM4E 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.